# Coherus Oncology, Inc.: filings

CHRS · Nasdaq · CIK 1512762 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chrs.md) · [Financials](/companies/chrs/financials.md) · [Filings](/companies/chrs/filings.md) · [Insiders](/companies/chrs/insiders.md)

## Reports and events: 278 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 342, 8-K 197, SC 13G/A 44, 10-Q 36, 3 34, DEFA14A 23, S-8 23, CORRESP 17, 4/A 16, SC 13G 16, 424B5 15, UPLOAD 15, 10-K 12, DEF 14A 12, CT ORDER 10, 425 8, D 8, EFFECT 8, S-1/A 6, SCHEDULE 13G/A 6, 8-K/A 5, S-3 5, SC 13D/A 5, ARS 4, 3/A 3, DRS/A 3, SCHEDULE 13G 3, 424B3 2, 424B4 2, FWP 2, S-1 2, SC 13D 2, 10-Q/A 1, 144 1, 8-A12B 1, CERTNAS 1, D/A 1, DEFM14A 1, DRS 1, DRSLTR 1, PRE 14A 1, PREM14A 1, S-1MEF 1, S-3/A 1, S-4 1, S-4/A 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 08:10 ET | [8-K](/filings/0001104659-26-119912.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-119912 |
| 2026-08-28 | 17:11 ET | [8-K](/filings/0001104659-26-103316.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-103316 |
| 2026-08-17 | 17:28 ET | [8-K](/filings/0001104659-26-097951.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-097951 |
| 2026-08-17 | 17:27 ET | [8-K](/filings/0001104659-26-097949.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-097949 |
| 2026-08-05 | 17:14 ET | [10-Q](/filings/0001104659-26-091262.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091262 |
| 2026-08-05 | 16:43 ET | [8-K](/filings/0001104659-26-091188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091188 |
| 2026-06-15 | 16:40 ET | [8-K](/filings/0001104659-26-074090.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-074090 |
| 2026-06-01 | 08:30 ET | [8-K](/filings/0001104659-26-068615.md) | 5.07 Shareholder vote results | 0001104659-26-068615 |
| 2026-05-11 | 16:43 ET | [10-Q](/filings/0001104659-26-058703.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058703 |
| 2026-05-11 | 16:16 ET | [8-K](/filings/0001104659-26-058666.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058666 |
| 2026-04-20 | 08:26 ET | [DEF 14A](/filings/0001104659-26-045251.md) | Proxy statement, period 2026-05-27 | 0001104659-26-045251 |
| 2026-03-09 | 16:56 ET | [10-K](/filings/0001104659-26-025308.md) | Annual report, period 2025-12-31 | 0001104659-26-025308 |
| 2026-03-09 | 16:40 ET | [8-K](/filings/0001104659-26-025293.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-025293 |
| 2026-02-17 | 16:05 ET | [8-K](/filings/0001104659-26-016378.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-016378 |
| 2026-02-04 | 08:40 ET | [8-K](/filings/0001104659-26-010065.md) | 8.01 Other events | 0001104659-26-010065 |
| 2026-01-23 | 17:27 ET | [8-K](/filings/0001104659-26-006307.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006307 |
| 2026-01-13 | 09:00 ET | [8-K](/filings/0001104659-26-003117.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-003117 |
| 2025-11-13 | 17:13 ET | [8-K](/filings/0001104659-25-111484.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-111484 |
| 2025-11-06 | 17:12 ET | [10-Q](/filings/0001104659-25-107852.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107852 |
| 2025-11-06 | 16:28 ET | [8-K](/filings/0001104659-25-107780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107780 |
| 2025-09-08 | 09:54 ET | [8-K](/filings/0001558370-25-011911.md) | 8.01 Other events | 0001558370-25-011911 |
| 2025-08-07 | 16:55 ET | [10-Q](/filings/0001558370-25-010803.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010803 |
| 2025-08-07 | 16:53 ET | [8-K](/filings/0001558370-25-010802.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010802 |
| 2025-07-03 | 16:10 ET | [8-K](/filings/0001558370-25-009085.md) | 3.01 Delisting notice | 0001558370-25-009085 |
| 2025-06-13 | 16:07 ET | [8-K](/filings/0001104659-25-059351.md) | 5.07 Shareholder vote results | 0001104659-25-059351 |
| 2025-05-30 | 16:05 ET | [8-K](/filings/0001558370-25-008294.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008294 |
| 2025-05-12 | 16:59 ET | [10-Q](/filings/0001558370-25-007418.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007418 |
| 2025-05-12 | 16:39 ET | [8-K](/filings/0001558370-25-007410.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007410 |
| 2025-04-29 | 16:05 ET | [DEF 14A](/filings/0001558370-25-005825.md) | Proxy statement, period 2025-06-11 | 0001558370-25-005825 |
| 2025-04-25 | 16:05 ET | [8-K](/filings/0001558370-25-005554.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-005554 |
| 2025-04-22 | 17:07 ET | [8-K](/filings/0001558370-25-005157.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-005157 |
| 2025-04-14 | 08:00 ET | [8-K](/filings/0001558370-25-004746.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-004746 |
| 2025-04-01 | 16:10 ET | [8-K](/filings/0001558370-25-004264.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004264 |
| 2025-03-17 | 16:28 ET | [10-K](/filings/0001558370-25-003126.md) | Annual report, period 2024-12-31 | 0001558370-25-003126 |
| 2025-03-13 | 06:02 ET | [8-K](/filings/0001558370-25-002842.md) | 5.07 Shareholder vote results | 0001558370-25-002842 |
| 2025-03-10 | 16:31 ET | [8-K](/filings/0001558370-25-002595.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002595 |
| 2025-03-04 | 08:32 ET | [8-K](/filings/0001558370-25-002117.md) | 8.01 Other events | 0001558370-25-002117 |
| 2025-01-13 | 16:25 ET | [8-K](/filings/0001558370-25-000167.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000167 |
| 2024-12-04 | 16:29 ET | [8-K](/filings/0001558370-24-016012.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-016012 |
| 2024-12-03 | 07:11 ET | [8-K](/filings/0001104659-24-124881.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-124881 |
| 2024-11-06 | 16:31 ET | [10-Q](/filings/0001558370-24-014648.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014648 |
| 2024-11-06 | 16:23 ET | [8-K](/filings/0001558370-24-014642.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014642 |
| 2024-09-13 | 17:15 ET | [8-K](/filings/0001558370-24-012783.md) | 7.01 Regulation FD disclosure | 0001558370-24-012783 |
| 2024-08-08 | 16:39 ET | [10-Q](/filings/0001558370-24-011629.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011629 |
| 2024-08-08 | 16:23 ET | [8-K](/filings/0001558370-24-011618.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-011618 |
| 2024-07-02 | 08:30 ET | [8-K](/filings/0001558370-24-009650.md) | 1.01 Entry into a material agreement | 0001558370-24-009650 |
| 2024-06-27 | 08:52 ET | [8-K](/filings/0001558370-24-009526.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009526 |
| 2024-06-05 | 09:11 ET | [8-K](/filings/0001558370-24-008918.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-008918 |
| 2024-06-04 | 16:05 ET | [8-K](/filings/0001558370-24-008898.md) | 5.07 Shareholder vote results | 0001558370-24-008898 |
| 2024-05-21 | 17:14 ET | [8-K/A](/filings/0001558370-24-008542.md) | 9.01 Financial statements and exhibits | 0001558370-24-008542 |

Page 1 of 6. [Older](/companies/chrs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.